Content analysis of marketing features in US nicotine pouch ads from 2021 to 2023
Lauren Czaplicki1, Dana Tfayli2, Tory R Spindle3
1Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA lczapli1@jhu.edu.
Introduction:
Since their 2016 US debut, nicotine pouches, which are available in various flavours and strengths, have grown in popularity. Nicotine pouches may appeal to people who use tobacco, but there is also concern that they may appeal to youth and non-nicotine users. This study analysed nicotine pouch advertising trends from 2021 to 2023 to explore advertising features and inform regulatory strategies.
Methods:
We conducted a content analysis of 2147 nicotine pouch print, radio, online/mobile, direct emails and social media ads from 2021 to 2023. Ads were coded for flavours, terms and claims. Two trained coders double-coded all ads, and any discrepancies were reconciled. We conducted χ2 and post-hoc tests to assess changes over time, using Bonferroni adjustments for multiple comparisons.
Results:
Most ads (84.6%) were posted on brands' social media accounts. Zyn ads comprised 54.5% of ads across media platforms. Most ads (72.3%) featured flavoured products, particularly fruit (27.1%) and mint (26.1%). Common terms included 'smoke-free' (19.2%), 'tobacco-free' (18.4%), 'synthetic' (12.9%) and 'spit-free' (10.6%), which all significantly declined from 2021 to 2023. The most common claim featured how convenient the product was to use, which significantly increased over time. Claims about product discreetness and the presence of coupons/discounts also significantly increased over time.
Conclusions:
We observed a decline in terms of connecting nicotine pouches to other tobacco products and an increase in potentially youth-appealing convenience claims. Future research should investigate how these features impact risk perceptions and use intentions among people who never and currently use tobacco to inform regulations (ie, restrict youth-appealing claims).
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
02:01Factorial Design
01:30Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...